Evidence map›Paper›PMID 31414712›Full record

ArticleThe EMBO journal2019

Bhlhe40 and Bhlhe41 transcription factors regulate alveolar macrophage self-renewal and identity.

René Rauschmeier, Charlotte Gustafsson, Annika Reinhardt, Noelia A-Gonzalez, Luigi Tortola, Dilay Cansever, Sethuraman Subramanian, Reshma Taneja, Moritz J Rossner, Michael H Sieweke and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 101 citations in OpenAlex.

  1. Targeting Microglial Transcriptional Reprogramming as a Therapy Strategy for Alzheimer's Disease.BioEssays : news and reviews in molecular, cellular and developmental biology · 2026
    Review
  2. Article
  3. Single-Cell Analysis Reveals the Soft Tissue Structure Heterogeneity Aggravates Peri-Implantitis Through MDK Signaling.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Comparative 5' IsomiRome Analysis Uncovers Dysregulated 5' IsomiRs inComputational and structural biotechnology journal · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. RACK1 promotes the development and function of alveolar macrophages through directly binding to and stabilizing PPARγ.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Progression in the In Vitro Macrophage Expansion.Journal of immunology research · 2025
    Review
  19. Article
  20. Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 9 institutions in 6 countries.

René RauschmeierResearch Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Vienna, Austria.
Charlotte GustafssonDepartment of Laboratory Medicine, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden.
Annika ReinhardtDivision of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Noelia A-GonzalezInstitute of Immunology, University of Münster, Münster, Germany.ORCID 0000-0003-0533-5216
Luigi TortolaInstitute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland.
Dilay CanseverInstitute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
Sethuraman SubramanianCNRS, INSERM, CIML, Aix Marseille University, Marseille, France.
Reshma TanejaDepartment of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore City, Singapore.ORCID 0000-0001-6214-6177
Moritz J RossnerDepartment of Psychiatry, Molecular Neurobiology, Ludwig Maximilian University, Munich, Germany.ORCID 0000-0002-0667-3420
Michael H SiewekeCNRS, INSERM, CIML, Aix Marseille University, Marseille, France.ORCID 0000-0002-3228-9537
Melanie GreterInstitute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
Robert MånssonDepartment of Laboratory Medicine, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden.
Meinrad BusslingerResearch Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Vienna, Austria.ORCID 0000-0002-9111-9351
Taras KreslavskyResearch Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Vienna, Austria.ORCID 0000-0002-6672-1914
Karolinska University Hospital · SECentre National de la Recherche Scientifique · FRResearch Institute of Molecular Pathology · ATUniversity of Zurich · CHETH Zurich · CHKarolinska Institutet · SELudwig-Maximilians-Universität München · DENational University of Singapore · SGUniversity of Münster · DE

Funding

Agence Nationale de la Recherche (ANR) ANR-11-BSV3-0026Åke Wibergs Stiftelse M18-0094Austrian Science Fund (FWF) P28841Cancerfonden (Swedish Cancer Society) CAN 2018/710Deutsche Forschungsgemeinschaft (DFG) RE 4264/1-1EC | H2020 | H2020 Priority Excellent Science | H2020 European Research Council (ERC) 695093 MacAgeFondation pour la Recherche Médicale (FRM) DEQ. 20110421320Österreichische Forschungsförderungsgesellschaft (FFG) FFG-852936Vetenskapsrådet (VR) 2017-01118
6 · The paper itself

Abstract

Tissues in multicellular organisms are populated by resident macrophages, which perform both generic and tissue-specific functions. The latter are induced by signals from the microenvironment and rely on unique tissue-specific molecular programs requiring the combinatorial action of tissue-specific and broadly expressed transcriptional regulators. Here, we identify the transcription factors Bhlhe40 and Bhlhe41 as novel regulators of alveolar macrophages (AMs)-a population that provides the first line of immune defense and executes homeostatic functions in lung alveoli. In the absence of these factors, AMs exhibited decreased proliferation that resulted in a severe disadvantage of knockout AMs in a competitive setting. Gene expression analyses revealed a broad cell-intrinsic footprint of Bhlhe40/Bhlhe41 deficiency manifested by a downregulation of AM signature genes and induction of signature genes of other macrophage lineages. Genome-wide characterization of Bhlhe40 DNA binding suggested that these transcription factors directly repress the expression of lineage-inappropriate genes in AMs. Taken together, these results identify Bhlhe40 and Bhlhe41 as key regulators of AM self-renewal and guardians of their identity.

Indexed as

AcetylationAnimalsBasic Helix-Loop-Helix ProteinsCell DifferentiationCell ProliferationCell Self RenewalCell SurvivalDown-RegulationGene Expression ProfilingGene Knockdown TechniquesHistonesHomeodomain ProteinsMacrophages, AlveolarMiceOrgan SpecificityPhenotypeBasic Helix-Loop-Helix ProteinsBhlhe40 protein, mouseBhlhe41 protein, mouseHistonesHomeodomain Proteinsalveolar macrophagesBhlhe40Bhlhe41self-renewaltissue-resident macrophages

Identifiers

PMID31414712
PMCPMC6769426
OpenAlexW2967087236

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.